Severe bronchial asthma. Current diagnostic and treatment options


DOI: https://dx.doi.org/10.18565/pharmateca.2019.5.110-120

I.V. Leshchenko (1, 2), T.Z. Buladzhova (2)

1) Ural State Medical University, Yekaterinburg, Russia; 2) Medical Association “New Hospital”, Yekaterinburg, Russia
The article contains a review of literature data on diagnostic criteria and modern approaches to the treatment of severe bronchial asthma (SBA), which has high medical and social importance. To confirm the diagnosis, an assessment of the allergological status, the determination of biological markers of the disease is necessary. The modern possibilities of treatment with monoclonal antibodies of this form of the disease, as well as the most studied options for future treatment of SBA are discussed.

About the Autors


Corresponding author: Roman E. Leshchenko, MD, Professor at the Department of Phthisiology and Pulmonology of the Ural State Medical University; Research Manager of the Clinic of the Medical Association “New Hospital”, Yekaterinburg, Russia; e-mail: leshchenkoiv@yandex.ru; ORCID: https://orcid.org/0000-0002-6168-0957; Address: 55, Gurzufskaya Street, Yekaterinburg 620102, Russian Federation


Similar Articles


Бионика Медиа